492 Results (Page 11 of 20)
US Markets Research Reports
US Antibacterial (Antibiotics) Drugs Market Analysis
US Antibacterial (Antibiotics) Drugs Market is at around $21.38 Bn in 2023 and is projected to reach $24.9 Bn in 2030, exhibiting a CAGR of 2.2% during the forecast period. Several factors, including the prevalence of infectious diseases, the development of antibiotic resistance, and technological advancements are driving growth in the market. The market is dominated by key players like Pfizer Inc., GlaxoSmithKline (GSK), Johnson & Johnson (J&J), Merck & Co., Inc., Abbott Laboratories, Astra Zeneca, Sanofi, F. Hoffmann-La Roche Ltd, Bayer AG, Bristol-Myers Squibb Company, Novartis AG, and Astellas Pharma Inc.
US Digital Therapeutics Market Analysis
US Digital Therapeutics Market is at around $2.6 Bn in 2023 and is projected to reach $12.6 Bn in 2030, exhibiting a CAGR of 27.2% during the forecast period. The market is being driven by factors such as the rise in chronic diseases, technological advancements, and the adoption of telehealth. The market is dominated by key players like DarioHealth Corp., Banner Health, Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
US Cardiovascular Drugs Market Analysis
US Cardiovascular Drug Market is at around $58.1 Bn in 2022 and is projected to reach $67.01 Bn in 2030, exhibiting a CAGR of 1.8% during the forecast period. The major reasons propelling the growth of this market are the increasing prevalence of chronic diseases, technological advancements, and the rise in government initiatives, among others. The market is dominated by key players like Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., Astra Zeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffman-La Roche Ltd.
US Dermatological Therapeutics Market Analysis
US Dermatological Therapeutics Market is at around $16.88 Bn in 2023 and is projected to reach $26.40 Bn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The development of innovative therapies, the growing trend of cosmetic dermatology, and the increasing prevalence of skin conditions are driving the growth of the market. The market is dominated by key players like Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.
US Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the US Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the US Vitamin and Minerals Market, offering unmatched value, accuracy, and expert insights.
US Telemedicine Market Analysis
US telemedicine market size is at around $25.54 Bn in 2022 and is projected to reach $84.88 Bn in 2030, exhibiting a CAGR of 16.2% during the forecast period. With 67 Mn people in the US reporting having active wearable devices with 82.38% willing to share the data collected with their healthcare providers telemedicine is an untapped and potentially sizeable market. Major players like MDlive, Amwell, Teladoc Health, and Doctor on Demand are yet to scale up to their maximum operations.
US Robotic Surgery Services Market Analysis
US's Robotic Surgery Service market size was valued at $1.80 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.3% % from 2022-30 and will reach $6.4Bn in 2030. The robotic surgery service market will grow due to robotic surgery technology having made complex surgical procedures more accessible, especially in rural areas where access to specialized surgeons may be limited. The market is segmented by product and service type, application type, and end user. Some of the major players are Intuitive Surgical (USA), Stryker Corporation (USA), Mazor Robotics (USA), Medtronic (USA), and others.
US Oncology Clinical Trials Market Analysis
This report presents a strategic analysis of the US Oncology Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the US Oncology Clinical Trials Market, offering unmatched value, accuracy, and expert insights.
US Lung Cancer Drugs Market Analysis
US Lung Cancer Drug Market is projected to grow from $4.015 Bn in 2022 to $6.546 Bn by 2030, registering a CAGR of 6.3% during the forecast period of 2022-30. The incidence of lung cancer is increasing globally, which is leading to a growing demand for lung cancer drugs in the US market. Key players operating in the market include Pfizer, Bristol-Myers Squibb, Merck, AstraZeneca, and Roche.
US Healthcare Diagnostics Market Analysis
This report presents a strategic analysis of the US Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the US Healthcare Diagnostics Market, offering unmatched value, accuracy, and expert insights.
US Electronic Health Records Market Analysis
US's Electronic Health Record market size was valued at $11.88 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 2% from 2022-30 and will reach $13.92 Bn in 2030. This growth can be attributed to the increasing adoption of EHR in healthcare facilities. The market is segmented by product type, application type, and end user. Some of the major players are Epic Systems, Allscripts, McKesson, Meditech, and others.
US Digital Health Market Analysis
US's Digital Health market is projected to grow from $88.6 Bn in 2022 to $302.7 Bn by 2030, registering a CAGR of 16.6% during the forecast period of 2022-30. One of the main factors driving the growth would be the prevalence of chronic diseases and patients being open to adopting new technologies as a part of patient care. The market is segmented by solution, by deployment, and by end-use. Some of the major players include Cerner Corporation, Allscripts & Apple Inc.
US Diabetes Therapeutics Market Analysis
US's diabetes therapeutics market is projected to grow from $60.4 Bn in 2022 to $109.4 Bn by 2030, registering a CAGR of 7.7% during the forecast period of 2022-30. Diabetes is a chronic disease that affects millions of people in the US. According to the Centers for Disease Control and Prevention (CDC), over 34 million people in the US have diabetes, and the prevalence of the disease is increasing. This has led to an increase in demand for diabetes therapeutics. Some of the key players in the US diabetes therapeutics market include Novo Nordisk, Sanofi, Eli Lilly and Company, AstraZeneca, and Merck & Co. These companies are focusing on research and development activities to introduce new and innovative drugs and therapies to address the unmet needs of diabetic patients.
US Contraceptive Devices Market Analysis
US's contraceptive devices market is projected to grow from $5.4 Bn in 2022 to $8.6 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The US contraceptive devices market is a growing and dynamic market that includes a range of products designed to prevent pregnancy. Bayer is a German multinational pharmaceutical company that manufactures a range of contraceptive products, including oral contraceptives and IUDs.
US Clinical Diagnostics Market Analysis
US's clinical diagnostic market was valued at $28.95 Bn in 2022 and is estimated to expand at a CAGR of 4% from 2022-30 and will reach $39.61 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and increased investment. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, bioMérieux, Danaher Corporation, Siemens, Qiagen, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Sysmex, Sonic Healthcare Ltd, Exact Sciences Corporation, NeoGenomics, Laboratory Corporation of America Holdings, and others.
US Alopecia (Hair Loss) Therapeutics Market Analysis
The US Alopecia (Hair Loss) Therapeutics Market was valued at US $3.444 Bn in 2022, and is predicted to grow at (CAGR) of 5.50% from 2023 to 2030, to US $5.285 Bn by 2030. The key drivers of this industry include the upward trend in the prevalence of alopecia (hair loss), technological advancements, and others. The industry is primarily dominated by players such as Eli Lilly, Johnson & Johnson, Cipla, Mylan, Theradome, and Pfizer, among others.
US Allergy Therapeutics Market Analysis
US Allergy Therapeutics Market was valued at $9744 Mn in 2022 and is estimated to reach $13751 Mn in 2030, exhibiting a CAGR of 4.4% during the forecast period. The market for allergy therapeutics is expanding as a result of the rising incidence of allergic illnesses and associated medical conditions. Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló, and Stallergenes Greer are few leading companies working in the allergy therapeutics market.
US Alcohol Addiction Therapeutics Market Analysis
The US Alcohol Addiction Therapeutics Market is valued at around $301 Mn in 2022 and is projected to reach $421 Mn by 2030, exhibiting a CAGR of 4.3% during the forecast period. The market is driven by a mix of factors, such as the increasing prevalence of alcohol addiction in the US, the presence of promising drugs in the pipeline and increased coverage of therapeutics by insurance providers. The key players involved in the research, development and distribution of Alcohol Addiction Therapeutics in US are Alkermes, TEVA, GlaxoSmithKline, Lundbeck, Eli Lilly, BioCorRx, Chronos, AstraZeneca, Roche, Opiant Pharmaceuticals, etc among others
US Cancer Immunotherapy Market Analysis
US's cancer immunotherapy market is projected to grow from $47.3 Bn in 2022 to $70.4 Bn by 2030, registering a CAGR of 5.1% during the forecast period of 2022-30. Cancer is a leading cause of death worldwide, and its prevalence is increasing due to factors such as an aging population and changing lifestyles. This has led to a growing demand for effective cancer treatments, including immunotherapies. Key players in the market include Bristol-Myers Squibb, Merck & Co., Inc., Novartis International AG, Roche Holding AG, AstraZeneca plc, Amgen Inc., and others.
US Artificial Intelligence (AI) in Healthcare Market Analysis
US Artificial Intelligence (AI) in the healthcare market is projected to grow from $2.9 Bn in 2022 to $51.3 Bn by 2030, registering a CAGR of 43.22% during the forecast period of 2022-30. The US Artificial Intelligence (AI) in the Healthcare market is a rapidly growing industry that involves the use of AI technologies to improve patient care, reduce costs, and increase efficiency in healthcare delivery. IBM Watson Health offers a range of AI-powered healthcare solutions, including clinical decision support, medical image analysis, and patient monitoring.
US Alexipharmic Drugs Market Analysis
US Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 2.70% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The US Alexipharmic Drugs market will grow because of the rising prevalence of various forms of chronic conditions and overdosing on prescription medications. The key market players are Pfizer Inc. (USA), Bristol-Myers Squibb Company (USA), Mylan N.V. (USA), and others.
US Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The US Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $1.386 Bn in 2022, and is predicted to grow at (CAGR) of 5.8% from 2023 to 2030, to US $2.176 Bn by 2030. The key drivers of this industry include the upward trend in the incidence of acute lymphocytic Leukemia cases, advancements in molecular biology and pharmacology technologies and other factors. The industry is primarily dominated by players such as Pfizer, Sanofi, Novartis, Takeda, Amgen Inc, among other players
US Digital Medical Simulation Market for Cadavers
The US digital medical simulation market for cadavers was valued at $0.7 Bn in 2022, projected to reach $2.8 Bn by 2030 with a 16.1% CAGR. The major reasons propelling the growth of this market are the increasing prevalence of chronic diseases, technological advancements, and the rise in government initiatives, among others. Some of the key players in this market are Simulab, CAE, 3D systems, Osso VR, and Vosaic among others.
US Addiction Therapeutics Market Analysis
US addiction therapeutics market was valued at $4242 Mn in 2022 and is estimated to reach $6220 Mn in 2030, exhibiting a CAGR of 4.9% during the forecast period. The market's growth is attributed to government initiatives to combat chronic drug use and advance prescription, as well as growing support for new drugs and the launch of cutting-edge therapies to treat addiction. Driving vital players working in the market include Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Titan Pharmaceutical, Indivior, Novartis, Cipla, Mylan, Glenmark and Alkermes
US Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The US Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $462 Mn in 2022 and is predicted to grow at a CAGR of 3.8% from 2023 to 2030, to US $623 Mn by 2030. The key drivers of this industry include the upward trend in the incidence of autosomal dominant polycystic kidney disease, the aging population, increased awareness, and other factors. The industry is primarily dominated by players such as Otsuka, Sanofi, Reata, and Janssen Pharmaceutical, among others